A cancer drug that targets the immune system may help improve the outlook for older adults with multiple myeloma, though a stem cell transplant remains the standard of care for relatively younger patients. Those are some of the findings from two studies in the Sept.
http://www.newsmax.com/Health-News/multiple-myeloma-stem-cell-transplant/2014/09/04/id/592624/
http://www.newsmax.com/Health-News/multiple-myeloma-stem-cell-transplant/2014/09/04/id/592624/
No comments:
Post a Comment